Back to search

Article

Cyp7b1-inhibiting azoles as novel enhancers of hematopoietic stem and progenitor cell mobilization

2025-10-14

Abstract excerpt

Mobilized hematopoietic stem and progenitor cells (HSPCs) are essential for transplantation-based therapies, including curative gene therapies for sickle cell disease (SCD). While granulocyte colony-stimulating factor (G-CSF, filgrastim) remains the standard mobilization agent, many patients respond inadequately, and it can trigger life-threatening vaso-occlusive crises in SCD. The CXCR4 antagonist AMD3100 (plerix...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
65d45971-4bd7-5634-a101-e19be367f3ea
DOI
10.1101/2025.10.13.682145
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 11 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cyp7b1-inhibiting azoles as novel enhancers of hematopoietic stem and progenitor cell mobilizationDOI 10.1101/2025.10.13.682145
Select a neighboring publication to make it the new centre.